Related Experiment Videos
ODC-polyamine system is involved in morphine analgesia.
S Genedani1, M Bernardi, S Tagliavini
1Institute of Pharmacology, University of Modena, Italy.
Life Sciences
|January 1, 1989
Summary
Alpha-Difluoromethylornithine (DFMO) inhibits brain ornithine decarboxylase (ODC) activity and reduces morphine
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Ornithine decarboxylase (ODC) is a key enzyme in polyamine synthesis.
- Polyamines are essential for cell growth and differentiation.
- The role of brain ODC in opioid analgesia is not well understood.
Purpose of the Study:
- To investigate the effect of alpha-difluoromethylornithine (DFMO) on brain ODC activity.
- To determine the influence of DFMO on morphine-induced analgesia.
- To explore the involvement of the brain ODC/polyamines system in opioid analgesia.
Main Methods:
- Direct infusion of DFMO into the brain ventricles of rats.
- Measurement of brain ODC activity.
- Assessment of morphine's analgesic activity and opiate binding sites.
Main Results:
- DFMO dose-dependently inhibited brain ODC activity.
- DFMO significantly reduced morphine's analgesic effect when ODC activity was substantially inhibited.
- DFMO did not affect opiate receptor binding sites or morphine's effect on ODC inhibition.
- Morphine increased ODC activity in specific brain areas (midbrain, brainstem).
Conclusions:
- The brain ODC/polyamines system may play a role in opioid analgesia.
- This role might be mediated at a post-receptorial level or via a non-opiate receptor mechanism.
- Targeting the ODC/polyamines system could be a potential strategy for modulating pain perception.